NL-OMON47794已完成4 期
BIoresorbable polymer-coated ORSIRO versus durable polymer-coated RESOLUTE ONYX stents [BIONYX]: A randomized Trial With stENT Evaluation in all-comers IV [TWENTE IV] - BIONYX (TWENTE IV)
CardioResearch Enschede0 个研究点目标入组 1,970 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,970
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients of 18 years and older, requiring PCI for the treatment of significant coronary artery or bypass graft lesions, being eligible for treatment with drug eluting stents according to clinical guidelines and/or the operators' judgement, and capable of providing informed consent. Patients with all clinical syndromes will be enrolled without any exclusion based on number, type, location or lenth of lesions to be treated.
排除标准
- •Known intolerance to components of one of the study DES, or known intolerance to antithrombotic and/or anticoagulant therapy that prevents adherence to any dual anti-platelet therapy (DAPT).
- •Planned elective surgical procedure necessitating interruption of DAPT during the first 3 months after randomization.
- •Participation in another randomized cardiovascular device trial or randomized pharmacological study related to antithrombotic and/or anticoagulant therapy before reaching the primary endpoint. Known pregnancy, adherence to scheduled follow-up is unlikely, or life expectancy is assumed to be less than 1 year
研究者
相似试验
Unknown
不适用
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX StentsCoronary StenosisCoronary RestenosisUnstable Angina PectorisAngina PectorisAcute Coronary SyndromeCoronary Artery DiseaseNCT02508714Thorax Centrum Twente2,470
进行中（未招募）
1 期
PERFORMANCE OF BIORESORBABLE POLYMER-COATED EVEROLIMUS-ELUTING SYNERGY® STENT IN PATIENTS AT HIGH BLEEDING RISK UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION FOLLOWED BY 1-MONTH DUAL ANTIPLATELET THERAPYCoronary artery disease with high-bleeding risk (HBR)MedDRA version: 20.0Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2016-004510-99-ITIRCCS ISTITUTO CLINICO HUMANITAS1,023
已完成
4 期
Comparison of Biodegradable Stents: Orsiro and BioMatrixAll-comerPercutaneous Coronary InterventionNCT02084901Yonsei University12
已完成
4 期
Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT): Randomized Multicenter Trial in an All Comers Population Treated Within thE NeThErlands 3 (TWENTE 3)NL-OMON43651Medisch Spectrum Twente3,540
已完成
不适用
HYBRID SIROLIMUS-ELUTING STENT WITH BIORESORBABLE POLYMER VERSUS EVEROLIMUS-ELUTING STENT WITH DURABABLE POLYMER FOR TOTAL OCCLUSIONS IN NATIVE CORONARY ARTERIES Primary Stenting of Occluded Native Coronary Arteries IV (PRISON IV)stenosis of coronary arteries10011082angina pectorisNL-OMON38171Sint Antonius Ziekenhuis250